Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a cataract that is affecting your vision and you are already planning to have cataract surgery.
- You have been diagnosed with mild to moderate open-angle glaucoma, including types called pigmentary glaucoma or pseudoexfoliation glaucoma.
- Your glaucoma is classified as "mild," meaning the nerve damage and vision test results meet specific measurements set by the trial (confirm with trial site).
- Your glaucoma is classified as "moderate," meaning your vision test results fall within a specific range of measurements set by the trial (confirm with trial site).
- Your eye pressure (measured in a standard eye clinic test) is between 10 and 31 mmHg while using your glaucoma medications, at the time surgery is being planned.
- You are willing and able to understand the study and sign a consent form agreeing to take part.
- You are willing and able to attend all follow-up eye appointments required by the study schedule.
Who may not be able to join:
- You have previously had certain laser treatments for glaucoma, such as argon laser trabeculoplasty, laser peripheral iridotomy, or a laser treatment targeting the eye's drainage area (cyclophotocoagulation), or you have had glaucoma surgery involving incisions.
- You had a specific type of laser glaucoma treatment (selective laser trabeculoplasty) within the last 90 days.
- The drainage angle inside your eye is blocked or closed over a large portion (confirm with trial site).
- You have scar tissue in a specific part of the drainage angle inside your eye (confirm with trial site).
- Even with the best glasses or contact lenses, your vision is worse than 20/200 (very limited vision).
- Your eye lens appears to be loose or wobbly during the pre-surgery examination (confirm with trial site).
- There is gel from inside your eye that has moved into the front part of your eye, found during the pre-surgery examination (confirm with trial site).
- You have an unusually small eye (a condition called nanophthalmos).
- You are taking blood-thinning or anti-clotting medications, unless it is only low-dose aspirin (81mg daily).
- You are currently being treated for another eye condition in either eye, such as receiving injections for a retinal condition or using steroids after a cornea transplant.
- There is something unusual about the eye being studied that could affect how eye pressure is measured (confirm with trial site).
- Your glaucoma is a type other than those listed above, including a type called normal tension glaucoma.
- You have a condition that raises pressure in the blood vessels around your eye, such as Sturge-Weber syndrome, Graves' disease, or a tumour behind the eye.
- You have a history of eye inflammation (uveitis) in either eye.
- It is not possible to carry out a standard eye examination to look at the drainage angle of your eye.
- You have taken steroid tablets in the last 90 days, or you are expected to need steroid tablets during the study.
- You take certain oral medications that can affect eye pressure, including tablets such as acetazolamide or methazolamide.
- You have previously had a rise in eye pressure caused by steroids.
- You are not well enough to attend the planned study visits.
- You are currently taking part in another research study that involves a medical treatment or intervention.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 617-573-3707
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intraocular pressure; Intraocular pressure-lowering medications
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.